Interestingly, HMGA1, SSRP1 and MT2A overexpression has been reported in breast cancer [19, 20, 31] and HMGA1 was previously described as a master regulator of the tumor progression in triple-negative breast cancer cells [32]. The gene discussed is MT2A; the disease is breast carcinoma.